Skip to main content

Day: September 6, 2023

Rapid7 Announces Upsized Pricing of $260 Million Convertible Senior Notes Offering

BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Rapid7, Inc. (“Rapid7”) (Nasdaq: RPD) today announced the pricing of $260.0 million aggregate principal amount of 1.25% convertible senior notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of the offering was increased from the previously announced offering size of $250.0 million. Rapid7 also granted the initial purchasers of the notes an option to purchase up to an additional $40.0 million aggregate principal amount of notes. The sale of the notes is expected to close on September 8, 2023, subject to customary closing conditions. The notes will be general unsecured obligations of Rapid7 and will accrue...

Continue reading

Nxu Strengthens Finance Team with Seasoned Accounting and Reporting Professional Jessica Murphy

Murphy Brings Hypergrowth Startup and Big Four Accounting Firm Experience as Nxu Focuses on Internal Efficiencies MESA, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) — Nxu Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company creating EV charging and energy storage solutions for the infrastructure we need to power our electrified future, is pleased to welcome Jessica Murphy, who joins the Company as Controller. Murphy’s deep experience in financial reporting and public company accounting in both rapid-growth startup settings and newly public company settings will bring valuable expertise in financial controls and operational expenditures. “Adding Jessica’s expertise to the team is a key part of our strategy to enhance the Company’s financial processes and reduce dependencies on external resources,” said Nxu Chief Financial...

Continue reading

Azimut and SOQUEM Uncover a Spodumene-Bearing Pegmatite Boulder Field at Galinée, James Bay Region, Quebec

LONGUEUIL, Quebec, Sept. 06, 2023 (GLOBE NEWSWIRE) — Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to report that a spodumene-bearing pegmatite boulder field containing at least 12 mineralized boulders has been identified on the Galinée Property (the “Property”) in the Eeyou Istchee James Bay region of Quebec. These encouraging preliminary field results obtained by Azimut and its partner SOQUEM Inc. (“SOQUEM”) confirm the strong prospectivity of the Property and support the upcoming maiden drilling program targeting the area immediately south of the Adina lithium discovery (Winsome Resources). The minimum 1,600-metre core drilling program will be initiated shortly. In addition to Galinée, substantial concurrent exploration programs are already underway or will soon commence following...

Continue reading

Photronics Reports Third Quarter Fiscal 2023 Results

BROOKFIELD, Conn., Sept. 06, 2023 (GLOBE NEWSWIRE) — Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2023 ended July 30, 2023. “The Photronics team performed well in the third quarter, maintaining strong margins in an environment where we experienced a temporary demand slowdown in some of our end markets,” said Frank Lee, chief executive officer. “Revenues increased 2% over the prior year quarter and were slightly lower than the record levels in the second quarter of this year. IC declined sequentially as softer mainstream demand more than offset high-end growth in Asia. FPD high-end demand was lower as strong AMOLED sales were offset by lower LTPS and G10.5+. “Despite lower revenue, we maintained good profit margins...

Continue reading

Pharvaris To Present at the 18th German Allergy Congress

ZUG, Switzerland, Sept. 06, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the acceptance of two abstracts for ePoster presentation at the 18th German Allergy Congress, taking place in Bonn, Germany, from September 14-16, 2023. Presentation details:Title: Efficacy and safety of the oral bradykinin B2 receptor antagonist deucrictibant immediate-release capsule (PHVS416) in treatment of hereditary angioedema attacks: results of RAPIDe-1 phase 2 trialPresenter: Emel Aygören-Pürsün, M.D.Date, Time: Friday, September 15, 5:15-6:30 p.m. CESTPoster ID: A-194Title: Early symptom relief following treatment with the oral bradykinin B2 receptor antagonist deucrictibant immediate-release...

Continue reading

Pharvaris To Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

ZUG, Switzerland, Sept. 06, 2023 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, will attend the Morgan Stanley 21st Annual Global Healthcare Conference, taking place in New York from September 11-13, 2023. Morgan Conn, Ph.D., Chief Business Officer of Pharvaris, will participate in a fireside chat on Monday, September 11, at 3:35 p.m. ET. A live audio webcast of the Morgan Stanley 21st Annual Global Healthcare Conference fireside chat will be available on the Investors section of the Pharvaris website at: https://ir.pharvaris.com/news-events/events-presentations. A replay will be available on Pharvaris’ website for 30 days following the presentation. About PharvarisBuilding on its deep-seated...

Continue reading

Digihost Reports on Energy Curtailment Programs and Provides August 2023 Production Update

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 4, 2022 to its short form base shelf prospectus dated February 23, 2022. HOUSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq: DGHI; TSXV: DGHI), an innovative U.S. based blockchain technology and computer infrastructure company, is pleased to provide unaudited comparative Bitcoin (“BTC”) production results for the month ended August 31, 2023, combined with an operations update. All monetary references are expressed in USD unless otherwise indicated. During the past month, Digihost participated, and continues to actively participate, in a variety of load curtailment programs that reduce BTC mining costs, as summer capacity pricing has been historically...

Continue reading

ZeroFox Announces Second Quarter Fiscal Year 2024 Financial Results

Achieves Positive Free Cash Flow – Record Quarterly Revenue of $62.2 Million WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) — ZeroFox Holdings, Inc. (Nasdaq: ZFOX), an enterprise software-as-a-service leader in external cybersecurity, today announced financial results for the second quarter ended July 31, 2023. “We had a very strong quarter with new record highs in quarterly revenue, ARR, subscription customers, large customer adoption, and positive free cash flow for the first time,” said James C. Foster, Chairman and CEO of ZeroFox. “The strong demand for our external cybersecurity platform reflects the growing need and the trust we are building with our customers as we offer a single, consolidated approach to address cyber threats that are outside the perimeter and beyond the endpoint. Today’s earnings announcement marks...

Continue reading

Home Infusion Therapy Market Size to Surpass USD 54.82 Billion by 2028, exhibiting a CAGR of 6.8%

As per the report by Fortune Business Insights, the global Home Infusion Therapy Market size is projected to reach USD 54.82 billion in 2028, at a CAGR of 6.8% during the forecast period, 2021-2028Home Infusion Therapy MarketForecast 2021-2028Pune, India, Sept. 06, 2023 (GLOBE NEWSWIRE) — Global Home Infusion Therapy Market Size was valued at USD 41.36 billion in 2020 and is projected to grow USD 54.82 billion by 2028 exhibiting a CAGR of 6.8% during the forecast period. The growing demand for personalized intravenous drug infusion therapy is expected to be the key growth driver for the market. The market’s growth is also ascribable to the expanding geriatric population and the growing chronic disease prevalence. The World Health Organization (WHO) estimates that around 40% of the total country’s populace experiences...

Continue reading

Digital Health Market Size to Surpass USD 4,547.70 Billion by 2030, exhibiting a CAGR of 29.5%

As per the report by Fortune Business Insights, the Global Digital Health Market size is projected to reach USD 4,547.70 Billion by 2030, at a CAGR of 29.5% during the forecast period.Digital Health MarketDigital Health Market (2022-2029)Pune, India, Sept. 06, 2023 (GLOBE NEWSWIRE) — The global digital health market size was estimated at USD 742.72 billion in 2022 and is expected to increase by USD 4,547.70 billion by 2029, representing a CAGR of 29.5% over the forecast period. The rising demand for personalized healthcare is also contributing to the growth of the market. Personalized healthcare is the tailoring of healthcare services to the individual needs of each patient. This can be done using data collected from wearable devices, telemedicine, and other sources. Fortune Business Insights™ stated this in a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.